This event has passed.

Roundtable on leveraging private investment in health and life sciences

Name: Roundtable on leveraging private investment in health and life sciences
Start: 2022-06-01T17:00:00+02:00
End: 2022-06-01T18:30:00+02:00

1 June 2022 @ 5:00 pm – 6:30 pm CEST

Investments in health innovation will be central to ensure better preparedness as we are aiming both to recover from the pandemic and to better anticipate future health challenges.

We are pleased to invite you to the launch of a novel report on European life science and health investment attractiveness as well as an exclusive conversation with global sector representatives on 1 June at 4:00 pm CET.

Three reasons to join:

Explore the nexus between the private investment and health agendas
Discuss how policy makers can scale up investments in health and life science innovation
Exchange with industry experts, OECD and government representatives

We look forward to your participation. For more information, please contact Ina Sandler.

Browse the agenda

Event Navigation

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.